5P
5D Patient Journey, Inc.
SEC filingBiotechnology · New Rochelle, NY
Amount raised$5.5Msold at filing
Total offering$6M$557K still open
Investors in the raise5count reported to the SEC
FiledJun 18, 2026first sale May 14, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Daniel ClarkExecutive Officer
Erick DaiExecutive Officer
Eric SchadtExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.